Necrotizing Soft-tissue Infections

• CLINICAL_TRIALS research · 2026-02-18
  Clinical Trial Update: Patients With Necrotizing Skin and Soft Tissue Infections Managed Within the SURFAST Care Pathway.

  This clinical trial update indicates that the SURFAST care pathway study for necrotizing soft-tissue infections is not yet recruiting.

• CLINICAL_TRIALS trial_result · 2021-10-05
  Clinical Trial Update: Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infections [Phase 3]

  Phase III trial evaluating AB103 for necrotizing soft tissue infections completed; results posted in 2021.

• CLINICAL_TRIALS trial_result · 2021-08-18
  Clinical Trial Update: Evaluation of Safety, PK and Immunomodulatory Effects of AB103 in Necrotizing Soft Tissue Infections Patients [Phase 2]

  Phase 2 clinical trial evaluating safety, pharmacokinetics, and immunomodulatory effects of AB103 in patients with necrotizing soft tissue i…